Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I F Hermans

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The Journal of Experimental Medicine|September 6, 2001
Killing of dendritic cells: a life cut short or a purposeful death?F Ronchese, I F Hermans
Scandinavian Journal of Immunology|December 9, 2004
B-Lymphocytes activated by CD40 ligand induce an antigen-specific anti-tumour immune response by direct and indirect activation of CD8(+) T-cellsD S Ritchie, J Yang, I F Hermans, et al.
Cancer Immunology, Immunotherapy : CII|August 1, 1997
Tumor-peptide-pulsed dendritic cells isolated from spleen or cultured in vitro from bone marrow precursors can provide protection against tumor challengeI F Hermans, A Daish, P Moroni-Rawson, et al.
The New Zealand Medical Journal|May 22, 1998
The emerging role of the dendritic cell in novel cancer therapiesI F Hermans, P Moroni-Rawson, F Ronchese, et al.
New Zealand Veterinary Journal|June 1, 1991
Three cases of disputed paternity in dogs resolved by the use of DNA fingerprintingI F Hermans, J Atkinson, J F Hamilton, et al.
Nucleic Acids Research|April 24, 1987
Chromosomal variations in Candida albicansR G Snell, I F Hermans, R J Wilkins, et al.
Cancer Research|September 10, 1998
Antigen expressed on tumor cells fails to elicit an immune response, even in the presence of increased numbers of tumor-specific cytotoxic T lymphocyte precursorsI F Hermans, A Daish, J Yang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2000
CD8+ T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunityI F Hermans, D S Ritchie, J Yang, et al.
The Journal of Experimental Medicine|April 6, 1999
Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) can regulate dendritic cell-induced activation and cytotoxicity of CD8(+) T cells independently of CD4(+) T cell helpK D McCoy, I F Hermans, J H Fraser, et al.
Cancer Research|September 2, 2000
Immunotherapy with dendritic cells and tumor major histocompatibility complex class I-derived peptides requires a high density of antigen on tumor cellsP Rawson, I F Hermans, S P Huck, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The Journal of Experimental Medicine|September 6, 2001
Killing of dendritic cells: a life cut short or a purposeful death?F Ronchese, I F Hermans
Scandinavian Journal of Immunology|December 9, 2004
B-Lymphocytes activated by CD40 ligand induce an antigen-specific anti-tumour immune response by direct and indirect activation of CD8(+) T-cellsD S Ritchie, J Yang, I F Hermans, et al.
Cancer Immunology, Immunotherapy : CII|August 1, 1997
Tumor-peptide-pulsed dendritic cells isolated from spleen or cultured in vitro from bone marrow precursors can provide protection against tumor challengeI F Hermans, A Daish, P Moroni-Rawson, et al.
The New Zealand Medical Journal|May 22, 1998
The emerging role of the dendritic cell in novel cancer therapiesI F Hermans, P Moroni-Rawson, F Ronchese, et al.
New Zealand Veterinary Journal|June 1, 1991
Three cases of disputed paternity in dogs resolved by the use of DNA fingerprintingI F Hermans, J Atkinson, J F Hamilton, et al.
Nucleic Acids Research|April 24, 1987
Chromosomal variations in Candida albicansR G Snell, I F Hermans, R J Wilkins, et al.
Cancer Research|September 10, 1998
Antigen expressed on tumor cells fails to elicit an immune response, even in the presence of increased numbers of tumor-specific cytotoxic T lymphocyte precursorsI F Hermans, A Daish, J Yang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2000
CD8+ T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunityI F Hermans, D S Ritchie, J Yang, et al.
The Journal of Experimental Medicine|April 6, 1999
Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) can regulate dendritic cell-induced activation and cytotoxicity of CD8(+) T cells independently of CD4(+) T cell helpK D McCoy, I F Hermans, J H Fraser, et al.
Cancer Research|September 2, 2000
Immunotherapy with dendritic cells and tumor major histocompatibility complex class I-derived peptides requires a high density of antigen on tumor cellsP Rawson, I F Hermans, S P Huck, et al.
Pageof 2